Data:
{
"symbol": "ASND",
"price": 242.66,
"marketCap": 15071999643,
"beta": 0.36,
"lastDividend": 0,
"range": "175.19-282.15",
"change": -0.79,
"changePercentage": -0.3245,
"volume": 217709,
"averageVolume": 686456,
"companyName": "Ascendis Pharma A/S",
"currency": "USD",
"cik": "0001612042",
"isin": "DK0060615755",
"cusip": "K08588103",
"exchangeFullName": "NASDAQ Global Select",
"exchange": "NASDAQ",
"industry": "Biotechnology",
"website": "https://ascendispharma.com",
"description": "Ascendis Pharma A/S is a biopharmaceutical enterprise dedicated to advancing therapeutic solutions for critical medical conditions that currently lack effective treatments. Its commercialized offering is SKYTROFA, a therapy prescribed for individuals suffering from growth hormone deficiency (GHD). The company boasts a robust development pipeline, featuring several TransCon-branded candidates. These include TransCon Growth Hormone (hGH), which is being progressed for pediatric GHD patients in Japan and for adults with GHD. Also under development are TransCon parathyroid hormone for adults with hypoparathyroidism, and TransCon CNP, aimed at treating pediatric achondroplasia. Further expanding its innovative portfolio, Ascendis is also developing a TransCon toll-like receptor (TLR) 7/8 agonist for intratumoral administration, alongside TransCon IL-2 \u00df/g, designed for systemic delivery. Founded in 2006, this enterprise maintains its corporate headquarters in Hellerup, Denmark.",
"ceo": "Jan Moller Mikkelsen",
"sector": "Healthcare",
"country": "DK",
"fullTimeEmployees": "1017",
"phone": "45 70 22 22 44",
"address": "Tuborg Boulevard 12",
"city": "Hellerup",
"state": "CR",
"zip": "2900",
"image": "https://images.financialmodelingprep.com/symbol/ASND.png",
"ipoDate": "2015-01-28",
"defaultImage": false,
"isEtf": false,
"isActivelyTrading": true,
"isAdr": true,
"isFund": false
}
Data:
{
"symbol": "ASND",
"name": "Ascendis Pharma A/S",
"price": 244.8399,
"changePercentage": 0.57092,
"change": 1.3899,
"volume": 366365.71922,
"dayLow": 239.56,
"dayHigh": 247.98,
"yearHigh": 282.15,
"yearLow": 175.19,
"marketCap": 15207396709,
"priceAvg50": 244.618,
"priceAvg200": 226.21762,
"exchange": "NASDAQ",
"open": 245.9,
"previousClose": 243.45,
"timestamp": 1785867944
}
Data:
{
"volume": 366365.71922,
"avgVolume": 686456,
"short_ratio": [
{
"symbol": "ASND",
"file_date": "2026-08-03",
"date": "20260803",
"short_volume": 140915,
"short_exempt_volume": 38,
"total_volume": 236724,
"short_volume_ratio": 0.5953,
"signal": "Bearish"
}
],
"volume_profile": {
"poc": 253.88,
"vah": 265.2,
"val": 240.5,
"profile": [
{
"price": 240.84,
"volume": 53906
},
{
"price": 241.53,
"volume": 58123
},
{
"price": 242.21,
"volume": 66483
},
{
"price": 242.9,
"volume": 101101
},
{
"price": 243.58,
"volume": 196614
},
{
"price": 244.27,
"volume": 385915
},
{
"price": 244.96,
"volume": 264326
},
{
"price": 245.64,
"volume": 73702
},
{
"price": 246.33,
"volume": 14624
},
{
"price": 247.02,
"volume": 7981
},
{
"price": 247.7,
"volume": 203448
},
{
"price": 248.39,
"volume": 165793
},
{
"price": 249.07,
"volume": 71114
},
{
"price": 249.76,
"volume": 47678
},
{
"price": 250.45,
"volume": 132514
},
{
"price": 251.13,
"volume": 59263
},
{
"price": 251.82,
"volume": 203241
},
{
"price": 252.51,
"volume": 349816
},
{
"price": 253.19,
"volume": 363178
},
{
"price": 253.88,
"volume": 572172
},
{
"price": 254.56,
"volume": 399052
},
{
"price": 255.25,
"volume": 432357
},
{
"price": 255.94,
"volume": 138780
},
{
"price": 256.62,
"volume": 85597
},
{
"price": 257.31,
"volume": 77244
},
{
"price": 258.0,
"volume": 53815
},
{
"price": 258.68,
"volume": 24790
},
{
"price": 259.37,
"volume": 7650
},
{
"price": 260.05,
"volume": 176887
},
{
"price": 260.74,
"volume": 48633
},
{
"price": 261.43,
"volume": 127840
},
{
"price": 262.11,
"volume": 86057
},
{
"price": 262.8,
"volume": 165156
},
{
"price": 263.49,
"volume": 200675
},
{
"price": 264.17,
"volume": 273445
},
{
"price": 264.86,
"volume": 279890
},
{
"price": 265.54,
"volume": 330116
},
{
"price": 266.23,
"volume": 150921
},
{
"price": 266.92,
"volume": 262907
},
{
"price": 267.6,
"volume": 137819
},
{
"price": 268.29,
"volume": 53848
},
{
"price": 268.98,
"volume": 36660
},
{
"price": 269.66,
"volume": 44152
},
{
"price": 270.35,
"volume": 135052
},
{
"price": 271.03,
"volume": 51177
},
{
"price": 271.72,
"volume": 70798
},
{
"price": 272.41,
"volume": 25374
},
{
"price": 273.09,
"volume": 21628
},
{
"price": 273.78,
"volume": 80819
},
{
"price": 274.47,
"volume": 162598
},
{
"price": 275.15,
"volume": 136467
},
{
"price": 275.84,
"volume": 71907
},
{
"price": 276.52,
"volume": 34458
},
{
"price": 277.21,
"volume": 179484
},
{
"price": 277.9,
"volume": 66817
},
{
"price": 278.58,
"volume": 68768
},
{
"price": 279.27,
"volume": 47453
},
{
"price": 279.96,
"volume": 79001
},
{
"price": 280.64,
"volume": 36980
},
{
"price": 281.33,
"volume": 55695
}
],
"sessions": 20
}
}
Data:
{
"symbol": "ASND",
"marketCap": 13190901095.0408,
"enterpriseValueTTM": 13515083023.807999,
"evToSalesTTM": 15.57908852712232,
"evToOperatingCashFlowTTM": 234.5015195577719,
"evToFreeCashFlowTTM": 320.96637159966355,
"evToEBITDATTM": 1092.5606916000827,
"netDebtToEBITDATTM": 26.20688461805234,
"currentRatioTTM": 0.9960745965771455,
"incomeQualityTTM": 0.11376591207479707,
"grahamNumberTTM": 38.25508378135618,
"grahamNetNetTTM": -10.351904021709064,
"taxBurdenTTM": -3.019001533043284,
"interestBurdenTTM": 33.39319908618007,
"workingCapitalTTM": -4427612,
"investedCapitalTTM": 135324979,
"returnOnAssetsTTM": 0.25262044274321693,
"operatingReturnOnAssetsTTM": -0.00419109319429834,
"returnOnTangibleAssetsTTM": 0.2530864965406158,
"returnOnEquityTTM": -56.419019614607144,
"returnOnInvestedCapitalTTM": 0.01506929323010143,
"returnOnCapitalEmployedTTM": -0.007898949425375425,
"earningsYieldTTM": 0.038672582885375395,
"freeCashFlowYieldTTM": 0.003192160467023027,
"capexToOperatingCashFlowTTM": 0.2693891140116671,
"capexToDepreciationTTM": 0.8925338878784544,
"capexToRevenueTTM": 0.01789684290040123,
"salesGeneralAndAdministrativeToRevenueTTM": 0.5726488272445265,
"researchAndDevelopementToRevenueTTM": 0.31293159084442024,
"stockBasedCompensationToRevenueTTM": 0.06992161010344465,
"intangiblesToTotalAssetsTTM": 0.0018414802993019662,
"averageReceivablesTTM": 177220435,
"averagePayablesTTM": 84644171.5,
"averageInventoryTTM": 308037195.5,
"daysOfSalesOutstandingTTM": 82.80715318497533,
"daysOfPayablesOutstandingTTM": 279.80494024754586,
"daysOfInventoryOutstandingTTM": 1119.1841691563523,
"operatingCycleTTM": 1201.9913223413275,
"cashConversionCycleTTM": 922.1863820937817,
"freeCashFlowToEquityTTM": 14660810.2,
"freeCashFlowToFirmTTM": -508856587.3895122,
"tangibleAssetValueTTM": 484789051,
"netCurrentAssetValueTTM": -393375817,
"grossProfitMarginTTM": 0.8817040868124062,
"ebitMarginTTM": -0.005792480564252293,
"ebitdaMarginTTM": 0.014259243122051509,
"operatingProfitMarginTTM": -0.007989235009171284,
"pretaxProfitMarginTTM": -0.19342945668490547,
"continuousOperationsProfitMarginTTM": 0.583963826267459,
"netProfitMarginTTM": 0.583963826267459,
"bottomLineProfitMarginTTM": 0.583963826267459,
"receivablesTurnoverTTM": 4.407831762850968,
"payablesTurnoverTTM": 1.3044801842207694,
"inventoryTurnoverTTM": 0.32613041719053193,
"fixedAssetTurnoverTTM": 6.375980992761672,
"assetTurnoverTTM": 0.43259604684403036,
"quickRatioTTM": 0.7170966752004685,
"solvencyRatioTTM": 0.3454393128750584,
"cashRatioTTM": 0.5083766504274774,
"priceToEarningsRatioTTM": 25.93091770451771,
"priceToEarningsGrowthRatioTTM": 0.05172046464459643,
"forwardPriceToEarningsGrowthRatioTTM": -0.9929658685863907,
"priceToEarningsDilutedRatioTTM": 28.129035231788073,
"priceToEarningsDilutedGrowthRatioTTM": 0.06307149763625158,
"priceToBookRatioTTM": 26.81704738927382,
"priceToSalesRatioTTM": 15.205398415851905,
"priceToFreeCashFlowRatioTTM": 313.267464252913,
"priceToOperatingCashFlowRatioTTM": 227.2931684226852,
"debtToAssetsRatioTTM": 0.447598162799613,
"debtToEquityRatioTTM": 1.8375278992171127,
"debtToCapitalRatioTTM": 0.6475805576128768,
"longTermDebtToCapitalRatioTTM": 0.4417289512720331,
"financialLeverageRatioTTM": 4.105307063201157,
"workingCapitalTurnoverRatioTTM": 49.361371038765704,
"operatingCashFlowRatioTTM": 0.05109610449538152,
"operatingCashFlowSalesRatioTTM": 0.06643491503382028,
"freeCashFlowOperatingCashFlowRatioTTM": 0.7306108686372355,
"debtServiceCoverageRatioTTM": 0.9901681069956653,
"interestCoverageRatioTTM": -0.037977110957937474,
"shortTermOperatingCashFlowCoverageRatioTTM": 0.11276524906155995,
"operatingCashFlowCoverageRatioTTM": 0.0642082206868132,
"capitalExpenditureCoverageRatioTTM": 3.7121024866531562,
"dividendPaidAndCapexCoverageRatioTTM": 3.7121024866531562,
"dividendPayoutRatioTTM": 0,
"dividendYieldTTM": 0,
"revenuePerShareTTM": 14.064329161400805,
"netIncomePerShareTTM": 8.213059470976617,
"interestDebtPerShareTTM": 17.51077914511239,
"cashPerShareTTM": 9.296365921755376,
"bookValuePerShareTTM": 7.919373558065329,
"tangibleBookValuePerShareTTM": 7.859504344598023,
"shareholdersEquityPerShareTTM": 7.919373558065329,
"operatingCashFlowPerShareTTM": 0.9343625128453433,
"capexPerShareTTM": 0.2517070895011219,
"freeCashFlowPerShareTTM": 0.6826554071320063,
"netIncomePerEBTTTM": -3.019001533043284,
"ebtPerEbitTTM": 24.211261336392923,
"priceToFairValueTTM": 26.81704738927382,
"debtToMarketCapTTM": 0.0680468372156945,
"effectiveTaxRateTTM": 4.019001533043284,
"enterpriseValueMultipleTTM": 1092.5607075876035,
"dividendPerShareTTM": 0,
"revenue_history": [
{
"date": "2025",
"revenue": 691710419
}
],
"dcf": {
"symbol": "ASND",
"date": "2026-08-04",
"dcf": -5034.715200496956,
"Stock Price": 243.4028
},
"statements": {
"income": [
{
"date": "2025-12-31",
"symbol": "ASND",
"reportedCurrency": "EUR",
"cik": "0001612042",
"filingDate": "2026-02-11",
"acceptedDate": "2026-02-11 16:15:33",
"fiscalYear": "2025",
"period": "FY",
"revenue": 691710419,
"costOfRevenue": 103179474,
"grossProfit": 588530944,
"researchAndDevelopmentExpenses": 283504142,
"generalAndAdministrativeExpenses": 0,
"sellingAndMarketingExpenses": 0,
"sellingGeneralAndAdministrativeExpenses": 435919569,
"otherExpenses": 0,
"operatingExpenses": 719423712,
"costAndExpenses": 822603187,
"netInterestIncome": -62766977,
"interestIncome": 14697112,
"interestExpense": 77464089,
"depreciationAndAmortization": 16997588,
"ebitda": -109796587,
"ebit": -126794175,
"nonOperatingIncomeExcludingInterest": -4098591,
"operatingIncome": -130892766,
"totalOtherIncomeExpensesNet": -73365497,
"incomeBeforeTax": -204258264,
"incomeTaxExpense": 14775875,
"netIncomeFromContinuingOperations": -219034140,
"netIncomeFromDiscontinuedOperations": 0,
"otherAdjustmentsToNetIncome": 0,
"netIncome": -219034140,
"netIncomeDeductions": 0,
"bottomLineNetIncome": -219034140,
"eps": -3.62,
"epsDiluted": -3.62,
"weightedAverageShsOut": 60607131,
"weightedAverageShsOutDil": 60607131
}
],
"balance_sheet": [
{
"date": "2025-12-31",
"symbol": "ASND",
"reportedCurrency": "EUR",
"cik": "0001612042",
"filingDate": "2026-02-11",
"acceptedDate": "2026-02-11 16:15:33",
"fiscalYear": "2025",
"period": "FY",
"cashAndCashEquivalents": 615778613,
"shortTermInvestments": 0,
"cashAndShortTermInvestments": 615778613,
"netReceivables": 157628833,
"accountsReceivables": 141272802,
"otherReceivables": 16356030,
"inventory": 301404570,
"prepaids": 33700639,
"otherCurrentAssets": 0,
"totalCurrentAssets": 1108512657,
"propertyPlantEquipmentNet": 146416610,
"goodwill": 3493511,
"intangibleAssets": 214907,
"goodwillAndIntangibleAssets": 3708419,
"longTermInvestments": 43377515,
"taxAssets": 0,
"otherNonCurrentAssets": 0,
"totalNonCurrentAssets": 193502546,
"otherAssets": 0,
"totalAssets": 1302015204,
"totalPayables": 97042648,
"accountPayables": 90618386,
"otherPayables": 6424261,
"accruedExpenses": 0,
"shortTermDebt": 486324774,
"capitalLeaseObligationsCurrent": 0,
"taxPayables": 0,
"deferredRevenue": 4941893,
"otherCurrentLiabilities": 480626206,
"totalCurrentLiabilities": 1068935521,
"longTermDebt": 385089911,
"capitalLeaseObligationsNonCurrent": 0,
"deferredRevenueNonCurrent": 1122520,
"deferredTaxLiabilitiesNonCurrent": 9618900,
"otherNonCurrentLiabilities": 0,
"totalNonCurrentLiabilities": 395831334,
"otherLiabilities": 0,
"capitalLeaseObligations": 0,
"totalLiabilities": 1464766855,
"treasuryStock": -79965.1,
"preferredStock": 0,
"commonStock": 8318454,
"retainedEarnings": -2699237842,
"additionalPaidInCapital": 2530001954,
"accumulatedOtherComprehensiveIncomeLoss": -1754252,
"otherTotalStockholdersEquity": 0,
"totalStockholdersEquity": -162751650,
"totalEquity": -162751650,
"minorityInterest": 0,
"totalLiabilitiesAndTotalEquity": 1302015204,
"totalInvestments": 43377515,
"totalDebt": 871414685,
"netDebt": 255636072
}
],
"cash_flow": [
{
"date": "2025-12-31",
"symbol": "ASND",
"reportedCurrency": "EUR",
"cik": "0001612042",
"filingDate": "2026-02-11",
"acceptedDate": "2026-02-11 16:15:33",
"fiscalYear": "2025",
"period": "FY",
"netIncome": -219034140,
"depreciationAndAmortization": 16997588,
"deferredIncomeTax": 3208178,
"stockBasedCompensation": 0,
"changeInWorkingCapital": 68159408,
"accountsReceivables": 14972785,
"inventory": -5686354,
"accountsPayables": -9963606,
"otherWorkingCapital": 68836583,
"otherNonCashItems": 182438801,
"netCashProvidedByOperatingActivities": 51769836,
"investmentsInPropertyPlantAndEquipment": -8150120,
"acquisitionsNet": 0,
"purchasesOfInvestments": 0,
"salesMaturitiesOfInvestments": 0,
"otherInvestingActivities": 0,
"netCashProvidedByInvestingActivities": -8150120,
"netDebtIssuance": -21091378,
"longTermNetDebtIssuance": 0,
"shortTermNetDebtIssuance": -21091378,
"netStockIssuance": 66931847,
"netCommonStockIssuance": 66931847,
"commonStockIssuance": 83641276,
"commonStockRepurchased": -16709428,
"netPreferredStockIssuance": 0,
"netDividendsPaid": 0,
"commonDividendsPaid": 0,
"preferredDividendsPaid": 0,
"otherFinancingActivities": -10946233,
"netCashProvidedByFinancingActivities": 34894236,
"effectOfForexChangesOnCash": 44131707,
"netChangeInCash": 122645659,
"cashAtEndOfPeriod": 615778613,
"cashAtBeginningOfPeriod": 493132954,
"operatingCashFlow": 51769836,
"capitalExpenditure": -8150119,
"freeCashFlow": 43619717,
"incomeTaxesPaid": 0,
"interestPaid": 0
}
]
}
}
Data:
{
"price": 244.112,
"rsi": 40.71370636426159,
"sma20": 257.5541,
"sma50": 244.59224000000006,
"sma200": 226.5763100000001,
"adx": 17.927109422878594,
"atr": 7.78,
"atr_pct": 3.19,
"high_52w": 277.18,
"low_52w": 69.96,
"structure": {
"ema8": 248.5822476637855,
"ema21": 252.32264834487307,
"ema50": 248.08289666294894,
"ema200": 226.4508332514071,
"checks": {
"price_above_all": false,
"ema_stacked": false,
"ema21_rising": false,
"ema50_rising": true,
"adx_over_30": false,
"higher_highs_lows": false,
"near_21ema": false
},
"dist_21ema_pct": -3.3,
"macd": {
"macd": -1.325,
"signal": 1.369,
"histogram": -2.694
},
"bollinger": {
"mid": 257.55,
"upper": 277.08,
"lower": 238.03,
"width_pct": 15.16
},
"crossover": {
"fresh_cross": false,
"pre_compressed": true,
"held_above_21": false,
"candles_since": 30,
"intraday_support": false
},
"momentum": {
"roc10": -4.3,
"checks": {
"roc_over_5": false,
"rsi_in_band": false,
"macd_expanding": false,
"top_quartile_3d": false,
"no_big_down": true,
"near_high": false
},
"volume": {
"rvol": 0.72,
"checks": {
"rvol_over_2": false,
"up_vol_beats_down": false,
"obv_new_high": false,
"surge_day": false,
"pullback_declining_vol": false,
"last_up_beats_down": false
}
}
},
"relative_strength": {
"sector": "Healthcare",
"sector_etf": "XLV",
"sector_etf_ret10d": 1.13,
"checks": {
"beats_spy_all": false,
"beats_sector_10d": false,
"rs_line_at_high": false,
"sector_top3": false
}
},
"commodity": {},
"universe": {
"checks": {
"price_over_20": true,
"avg_vol_over_2m": false,
"mcap_over_1b": true,
"no_earnings_7d": false,
"not_lev_etf_spac": true,
"bidask_spread": null,
"dollar_vol_over_10m": true
},
"avg_dollar_vol": 166575412.96,
"avg_vol": 686456
},
"options": {
"checks": {
"call_vol_2x": false,
"ivr_under_40": false,
"iv_contracting": true,
"oi_calls_above_price": false
},
"vals": {
"call_vol_mult": 0.0,
"iv_rank": 61.0
}
}
}
}
Data:
{
"prior_day": {
"high": 247.98,
"low": 239.56,
"close": 244.51,
"date": "2026-08-04"
},
"woodie_pivots": {
"PP": 244.14,
"R1": 248.72,
"S1": 240.3,
"R2": 252.56,
"S2": 235.72
},
"swing": {
"high_20d": 282.15,
"low_20d": 239.56,
"high_60d": 282.15,
"low_60d": 203.8
},
"orb": {
"high": 247.98,
"low": 243.09,
"date": "2026-08-04"
},
"vwap": 242.86,
"volume_profile": {
"poc": 253.88,
"vah": 265.2,
"val": 240.5,
"sessions": 20
},
"recent_daily": [
{
"d": "2026-06-30",
"o": 265,
"h": 269.351,
"l": 262.76,
"c": 266.72,
"v": 630505.783368
},
{
"d": "2026-07-01",
"o": 267.51,
"h": 268.225,
"l": 262.18,
"c": 267.79,
"v": 541765.260654
},
{
"d": "2026-07-02",
"o": 270.9,
"h": 274.89,
"l": 265.755,
"c": 274.5,
"v": 552426.858348
},
{
"d": "2026-07-06",
"o": 274.26,
"h": 274.56,
"l": 266.05,
"c": 267.92,
"v": 547134.695757
},
{
"d": "2026-07-07",
"o": 269.86,
"h": 273.8,
"l": 266.65,
"c": 266.97,
"v": 627616.062943
},
{
"d": "2026-07-08",
"o": 265.37,
"h": 277.83,
"l": 265.37,
"c": 277.18,
"v": 739669.767364
},
{
"d": "2026-07-09",
"o": 277.56,
"h": 282.15,
"l": 274.07,
"c": 275.43,
"v": 667135.243392
},
{
"d": "2026-07-10",
"o": 275.43,
"h": 276.91,
"l": 267.85,
"c": 270.45,
"v": 375370.085458
},
{
"d": "2026-07-13",
"o": 267.02,
"h": 267.03,
"l": 262.02,
"c": 265.22,
"v": 601078.052823
},
{
"d": "2026-07-14",
"o": 265.79,
"h": 268.14,
"l": 263.275,
"c": 265.57,
"v": 516502.387057
},
{
"d": "2026-07-15",
"o": 265.01,
"h": 268.77,
"l": 260.9,
"c": 268.57,
"v": 441977.32557
},
{
"d": "2026-07-16",
"o": 267.39,
"h": 267.39,
"l": 259.22,
"c": 259.8,
"v": 485853.11564
},
{
"d": "2026-07-17",
"o": 259.5,
"h": 267.5,
"l": 259.2,
"c": 261,
"v": 668250.296232
},
{
"d": "2026-07-20",
"o": 262.15,
"h": 263.26,
"l": 251.71,
"c": 251.76,
"v": 515428.358122
},
{
"d": "2026-07-21",
"o": 252.72,
"h": 257.12,
"l": 250.03,
"c": 255.2,
"v": 549019.577621
},
{
"d": "2026-07-22",
"o": 255.2,
"h": 257.71,
"l": 251.68,
"c": 251.93,
"v": 412323.870076
},
{
"d": "2026-07-23",
"o": 251.55,
"h": 256.09,
"l": 249.99,
"c": 252.66,
"v": 308315.160657
},
{
"d": "2026-07-24",
"o": 254.4,
"h": 258.855,
"l": 251.99,
"c": 253.86,
"v": 390365.552963
},
{
"d": "2026-07-27",
"o": 255.56,
"h": 258.58,
"l": 252.93,
"c": 253.42,
"v": 365407.896398
},
{
"d": "2026-07-28",
"o": 255.53,
"h": 255.53,
"l": 246.62,
"c": 254.44,
"v": 578553.610195
},
{
"d": "2026-07-29",
"o": 254.94,
"h": 260.22,
"l": 251.66,
"c": 252.05,
"v": 507090.772968
},
{
"d": "2026-07-30",
"o": 250,
"h": 253.065,
"l": 245.84,
"c": 251.07,
"v": 475233.114523
},
{
"d": "2026-07-31",
"o": 249.71,
"h": 252.46,
"l": 243.3,
"c": 243.91,
"v": 508877.772507
},
{
"d": "2026-08-03",
"o": 244.68,
"h": 245.66,
"l": 239.93,
"c": 243.45,
"v": 622950.616607
},
{
"d": "2026-08-04",
"o": 245.9,
"h": 247.98,
"l": 239.56,
"c": 244.515,
"v": 365884.71922
}
]
}
Data:
{
"estimates": [
{
"symbol": "ASND",
"date": "2030-12-31",
"revenueLow": 3066232560,
"revenueHigh": 3732498635,
"revenueAvg": 3344365054,
"ebitdaLow": -2953365742,
"ebitdaHigh": -2426178034,
"ebitdaAvg": -2646252322,
"ebitLow": -3008073833,
"ebitHigh": -2471120510,
"ebitAvg": -2695271450,
"netIncomeLow": 1112532394,
"netIncomeHigh": 1435590832,
"netIncomeAvg": 1247392960,
"sgaExpenseLow": 16677179910,
"sgaExpenseHigh": 20300988276,
"sgaExpenseAvg": 18189937195,
"epsAvg": 20.58162,
"epsHigh": 23.68683,
"epsLow": 18.35646,
"numAnalystsRevenue": 6,
"numAnalystsEps": 5
},
{
"symbol": "ASND",
"date": "2029-12-31",
"revenueLow": 2715691332,
"revenueHigh": 3305787800,
"revenueAvg": 2962026856,
"ebitdaLow": -2615727799,
"ebitdaHigh": -2148809827,
"ebitdaAvg": -2343724539,
"ebitLow": -2664181491,
"ebitHigh": -2188614340,
"ebitAvg": -2387139648,
"netIncomeLow": 975584518,
"netIncomeHigh": 1258875587,
"netIncomeAvg": 1093844185,
"sgaExpenseLow": 14770592914,
"sgaExpenseHigh": 17980116252,
"sgaExpenseAvg": 16110407091,
"epsAvg": 18.04811,
"epsHigh": 20.77108,
"epsLow": 16.09686,
"numAnalystsRevenue": 11,
"numAnalystsEps": 10
},
{
"symbol": "ASND",
"date": "2028-12-31",
"revenueLow": 2089576076,
"revenueHigh": 2778669921,
"revenueAvg": 2482216081,
"ebitdaLow": -2198642077,
"ebitdaHigh": -1653391736,
"ebitdaAvg": -1964070896,
"ebitLow": -2239369682,
"ebitHigh": -1684019133,
"ebitAvg": -2000453308,
"netIncomeLow": 448769751,
"netIncomeHigh": 1623359606,
"netIncomeAvg": 793016671,
"sgaExpenseLow": 11365164081,
"sgaExpenseHigh": 15113132248,
"sgaExpenseAvg": 13500725515,
"epsAvg": 15.41699,
"epsHigh": 26.78496,
"epsLow": 7.40457,
"numAnalystsRevenue": 12,
"numAnalystsEps": 12
},
{
"symbol": "ASND",
"date": "2027-12-31",
"revenueLow": 1886239018,
"revenueHigh": 2153240888,
"revenueAvg": 1955142727,
"ebitdaLow": -1703766965,
"ebitdaHigh": -1492499862,
"ebitdaAvg": -1547020405,
"ebitLow": -1735327512,
"ebitHigh": -1520146901,
"ebitAvg": -1575677382,
"netIncomeLow": 355111126,
"netIncomeHigh": 1296593829,
"netIncomeAvg": 578468609,
"sgaExpenseLow": 10259217734,
"sgaExpenseHigh": 11711435769,
"sgaExpenseAvg": 10633983682,
"epsAvg": 10.42545,
"epsHigh": 21.39342,
"epsLow": 5.85923,
"numAnalystsRevenue": 12,
"numAnalystsEps": 10
}
],
"price_target": {
"symbol": "ASND",
"targetHigh": 345,
"targetLow": 255,
"targetConsensus": 291.58,
"targetMedian": 277.5
},
"ratings": {
"symbol": "ASND",
"rating": "B-",
"overallScore": 3,
"discountedCashFlowScore": 1,
"returnOnEquityScore": 5,
"returnOnAssetsScore": 5,
"debtToEquityScore": 1,
"priceToEarningsScore": 2,
"priceToBookScore": 1
},
"grades": [
{
"symbol": "ASND",
"date": "2026-07-23",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "ASND",
"date": "2026-07-07",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "ASND",
"date": "2026-05-15",
"gradingCompany": "Evercore ISI Group",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "ASND",
"date": "2026-05-11",
"gradingCompany": "Barclays",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "ASND",
"date": "2026-05-08",
"gradingCompany": "Wells Fargo",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "ASND",
"date": "2026-04-16",
"gradingCompany": "B of A Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "ASND",
"date": "2026-04-09",
"gradingCompany": "Wedbush",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "ASND",
"date": "2026-03-03",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "ASND",
"date": "2026-02-12",
"gradingCompany": "Oppenheimer",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "ASND",
"date": "2026-02-12",
"gradingCompany": "Wedbush",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "ASND",
"date": "2026-01-30",
"gradingCompany": "B of A Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "ASND",
"date": "2026-01-20",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "ASND",
"date": "2026-01-20",
"gradingCompany": "Wells Fargo",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "ASND",
"date": "2026-01-09",
"gradingCompany": "Wells Fargo",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "ASND",
"date": "2026-01-07",
"gradingCompany": "TD Cowen",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "ASND",
"date": "2025-12-11",
"gradingCompany": "Stifel",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "ASND",
"date": "2025-11-18",
"gradingCompany": "Wedbush",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "ASND",
"date": "2025-10-13",
"gradingCompany": "Cantor Fitzgerald",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "ASND",
"date": "2025-10-09",
"gradingCompany": "JP Morgan",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "ASND",
"date": "2025-09-02",
"gradingCompany": "B of A Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "ASND",
"date": "2025-08-19",
"gradingCompany": "JP Morgan",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "ASND",
"date": "2025-08-08",
"gradingCompany": "Wedbush",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "ASND",
"date": "2025-08-08",
"gradingCompany": "Cantor Fitzgerald",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "ASND",
"date": "2025-08-08",
"gradingCompany": "Wells Fargo",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "ASND",
"date": "2025-08-08",
"gradingCompany": "RBC Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "ASND",
"date": "2025-08-08",
"gradingCompany": "UBS",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "ASND",
"date": "2025-08-08",
"gradingCompany": "Citigroup",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "ASND",
"date": "2025-08-08",
"gradingCompany": "Stifel",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
}
]
}
Data:
[
{
"title": "Artisan Small Cap Fund Trimmed Ascendis Pharma (ASND) Amid Lawsuit Concerns",
"url": "https://finance.yahoo.com/news/artisan-small-cap-fund-trimmed-150348854.html",
"source": "Yahoo! Finance",
"date": "2026-07-24T15:03:48Z",
"summary": "Artisan Partners, an investment management company, released its second-quarter 2026 investor letter for its \"Artisan Small Cap Fund\". A copy of the letter can be downloaded here. The fund reported strong absolute returns and modestly outperformed the Russell 2000\u00ae Growth Index, "
},
{
"title": "Ascendis Pharma (ASND) Stock Looks Above Fair Value As Shares Jump 24%",
"url": "https://finance.yahoo.com/markets/stocks/articles/ascendis-pharma-asnd-stock-looks-061116679.html",
"source": "Yahoo! Finance",
"date": "2026-07-12T06:11:16Z",
"summary": "Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE.\n\nAscendis Pharma stock has climbed 24.0% over the past month, yet the current valuation checks and market multiples point to a picture that is not clearly cheap or c"
},
{
"title": "Why Crinetics Stock Soared 99% This Week",
"url": "https://finance.yahoo.com/markets/stocks/articles/why-crinetics-stock-soared-99-172939023.html",
"source": "Yahoo! Finance",
"date": "2026-07-09T17:29:39Z",
"summary": "* Vertex's $85-per-share all-cash acquisition sent CRNX up 116% on a franchise the company projects will exceed $5B in peak annual sales.\n\n* NBIX gained 6% and CORT rose 5% as investors repriced endocrine rare-disease specialists as potential M&A targets following the deal.\n\n* Tr"
},
{
"title": "14 value stocks of companies primed for rapid growth through 2028",
"url": "https://www.marketwatch.com/story/14-value-stocks-of-companies-primed-for-rapid-growth-through-2028-ea754ffa",
"source": "Market Watch",
"date": "2026-07-01 12:10:00",
"summary": "Let us begin with a midyear summary of index results that might surprise you in light of the triple-digit gains for so many growth stocks in the S&P 500."
},
{
"title": "Big Pharma Has a Case of Merger Mania",
"url": "https://www.fool.com/investing/2026/06/30/big-pharma-has-a-case-of-merger-mania/?source=iedfolrf0000001",
"source": "The Motley Fool",
"date": "2026-06-30T04:26:13Z",
"summary": "The pharmaceutical industry is experiencing a record-breaking M&A wave in 2026, driven by looming patent cliffs worth $300 billion in annual revenue, FDA regulatory improvements for rare diseases, and the need to diversify portfolios. Companies are making strategic bolt-on acquis"
},
{
"title": "Children with Achondroplasia Treated with TransCon CNP Showed Continued Improvements in Lower Extremity Alignment at Week 104 of the Pivotal ApproaCH Trial",
"url": "https://www.globenewswire.com/news-release/2026/06/30/3319671/0/en/Children-with-Achondroplasia-Treated-with-TransCon-CNP-Showed-Continued-Improvements-in-Lower-Extremity-Alignment-at-Week-104-of-the-Pivotal-ApproaCH-Trial.html",
"source": "GlobeNewsWire",
"date": "2026-06-30 08:30:00",
"summary": "COPENHAGEN, Denmark, June 30, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced new radiographic data from Week 104 from the completed pivotal ApproaCH Trial of once-weekly TransCon CNP (navepegritide) in children with achondroplasia. In the trial, Trans"
},
{
"title": "Ascendis Joins Multiple Russell U.S. Indexes, Including the Russell 3000\u00ae, Russell 1000\u00ae, Russell 2500\u00ae and Russell Midcap\u00ae",
"url": "https://www.globenewswire.com/news-release/2026/06/26/3318446/0/en/Ascendis-Joins-Multiple-Russell-U-S-Indexes-Including-the-Russell-3000-Russell-1000-Russell-2500-and-Russell-Midcap.html",
"source": "GlobeNewsWire",
"date": "2026-06-26 16:01:00",
"summary": "COPENHAGEN, Denmark, June 26, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that the Company has been added to the broad-market Russell 3000\u00ae Index, the large-cap Russell 1000\u00ae Index, the small-to-mid-cap Russell 2500\u00ae Index, and the Russell Midcap\u00ae "
},
{
"title": "Ascendis Pharma (ASND) Moves 9.9% Higher: Will This Strength Last?",
"url": "https://www.zacks.com/stock/news/2943771/ascendis-pharma-asnd-moves-9-9-higher-will-this-strength-last?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|daily_price_change_3%-2943771",
"source": "Zacks Investment Research",
"date": "2026-06-26 11:45:28",
"summary": "Ascendis Pharma (ASND) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road."
},
{
"title": "Ascendis to Showcase Advances in Treatment of Achondroplasia at ICCBH 2026",
"url": "https://www.globenewswire.com/news-release/2026/06/25/3317923/0/en/Ascendis-to-Showcase-Advances-in-Treatment-of-Achondroplasia-at-ICCBH-2026.html",
"source": "GlobeNewsWire",
"date": "2026-06-25 16:01:00",
"summary": "COPENHAGEN, Denmark, June 25, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that the latest data from its clinical development programs for the treatment of children with achondroplasia will be shared in an oral presentation and two posters at ICCBH "
},
{
"title": "Phase 3 Data Show TransCon\u00ae PTH Replicated Systemic Actions of Endogenous PTH Through Week 182 in Adults with Hypoparathyroidism",
"url": "https://www.globenewswire.com/news-release/2026/06/13/3311416/0/en/Phase-3-Data-Show-TransCon-PTH-Replicated-Systemic-Actions-of-Endogenous-PTH-Through-Week-182-in-Adults-with-Hypoparathyroidism.html",
"source": "GlobeNewsWire",
"date": "2026-06-13 16:00:00",
"summary": "COPENHAGEN, Denmark, June 13, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced Week 182 data from its completed Phase 3 PaTHway Trial showing that long-term treatment with TransCon PTH (palopegteriparatide) demonstrated sustained efficacy and safety in "
},
{
"title": "Why Is Ascendis Pharma Stock Gaining Friday?",
"url": "https://www.benzinga.com/news/health-care/26/06/53172465/why-is-ascendis-pharma-stock-gaining-friday?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel",
"source": "Benzinga",
"date": "2026-06-12T16:29:22Z",
"summary": "Ascendis Pharma reported positive five-year results from its PaTH Forward trial for TransCon PTH (YORVIPATH), showing sustained efficacy and safety in treating adult hypoparathyroidism. The therapy demonstrated that 82% of patients met composite response endpoints, with 88% maint"
},
{
"title": "Touchstone Mid Cap Growth Fund Q1 2026 Portfolio Review",
"url": "https://seekingalpha.com/article/4914576-touchstone-mid-cap-growth-fund-q1-2026-portfolio-review",
"source": "Seeking Alpha",
"date": "2026-06-12 09:55:00",
"summary": "The Touchstone Mid Cap Growth Fund (Class A Shares, Load Waived) outperformed its benchmark, the Russell Midcap Growth Index, for the quarter ended March 31, 2026. Among the top contributors to relative performance during the quarter were Vertiv Holdings, Ascendis Pharma, Howmet "
},
{
"title": "5-Year Phase 2 Data Show TransCon\u00ae PTH Replicated Systemic Actions of Endogenous PTH in Adults with Hypoparathyroidism",
"url": "https://www.globenewswire.com/news-release/2026/06/11/3310783/0/en/5-Year-Phase-2-Data-Show-TransCon-PTH-Replicated-Systemic-Actions-of-Endogenous-PTH-in-Adults-with-Hypoparathyroidism.html",
"source": "GlobeNewsWire",
"date": "2026-06-11 16:01:00",
"summary": "\u2013 Multi-organ system and quality-of-life benefits sustained through five years of treatment \u2013 82% response rate for the multi-component endpoint \u2013 95% of patients completed five years of treatment COPENHAGEN, Denmark, June 11, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:"
},
{
"title": "Ascendis to Showcase Advances in Treatment of Rare Endocrine Diseases at ENDO 2026",
"url": "https://www.globenewswire.com/news-release/2026/06/08/3308479/0/en/Ascendis-to-Showcase-Advances-in-Treatment-of-Rare-Endocrine-Diseases-at-ENDO-2026.html",
"source": "GlobeNewswire Inc.",
"date": "2026-06-08T20:59:00Z",
"summary": "Ascendis Pharma announced it will present clinical trial data from its rare endocrinology programs at ENDO 2026, including two oral presentations and three posters covering hypoparathyroidism, achondroplasia, and pediatric growth hormone deficiency. The presentations will showcas"
},
{
"title": "Ascendis Pharma: Rare Endocrine Compounder Entering Growth Phase (Initiating Buy)",
"url": "https://seekingalpha.com/article/4909444-ascendis-pharma-rare-endocrine-compounder-entering-growth-phase-initiating-buy",
"source": "Seeking Alpha",
"date": "2026-05-28 00:16:34",
"summary": "Ascendis Pharma is initiated with a buy rating, reflecting its transition to a durable, commercial-stage rare endocrine franchise. ASND's valuation premium is justified by high-quality revenue growth, multiple product launches, operating leverage, and reduced financing risk. Yorv"
},
{
"title": "Ascendis Pharma A/S (ASND) Q1 2026 Earnings Call Transcript",
"url": "https://seekingalpha.com/article/4900662-ascendis-pharma-a-s-asnd-q1-2026-earnings-call-transcript",
"source": "Seeking Alpha",
"date": "2026-05-09 01:01:16",
"summary": "Ascendis Pharma A/S (ASND) Q1 2026 Earnings Call Transcript"
},
{
"title": "Ascendis Pharma Reports First Quarter 2026 Financial Results",
"url": "https://www.globenewswire.com/news-release/2026/05/07/3289866/0/en/ascendis-pharma-reports-first-quarter-2026-financial-results.html",
"source": "GlobeNewsWire",
"date": "2026-05-07 07:30:00",
"summary": "- Q1 2026 revenue of \u20ac197 million for YORVIPATH \u00ae\u00a0and \u20ac44 million for SKYTROFA \u00ae - More than 1,000 new patient enrollments for YORVIPATH in the U.S. in Q1 - As of May 1, more than 60 YUVIWEL \u00ae enrollments since early April U.S. commercial launch - Entered into agreement to sell R"
},
{
"title": "New 2-Year Data from Pivotal ApproaCH Trial of TransCon\u00ae CNP (Navepegritide) Show Pronounced Gains in Growth Outcomes in Children with Achondroplasia Aged \u22655 Years",
"url": "https://www.globenewswire.com/news-release/2026/05/06/3289301/0/en/New-2-Year-Data-from-Pivotal-ApproaCH-Trial-of-TransCon-CNP-Navepegritide-Show-Pronounced-Gains-in-Growth-Outcomes-in-Children-with-Achondroplasia-Aged-5-Years.html",
"source": "GlobeNewsWire",
"date": "2026-05-06 16:01:00",
"summary": "COPENHAGEN, Denmark, May 06, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced new data from a subgroup analysis showing that children with achondroplasia \u22655 years of age at enrollment treated with once-weekly TransCon CNP (navepegritide) in its pivotal "
},
{
"title": "Stifel cuts Crinetics stock rating to hold on Vertex acquisition By Investing.com",
"url": "https://www.investing.com/news/analyst-ratings/stifel-cuts-crinetics-stock-rating-to-hold-on-vertex-acquisition-93CH-4781829",
"source": "Investing.com",
"date": "2026-04-20T18:08:21Z",
"summary": "Investing.com - Stifel downgraded Crinetics Pharmaceuticals (NASDAQ:CRNX) to Hold from Buy on Wednesday while raising its price target to $85 from $83 following the proposed acquisition by Vertex Pharmaceuticals.\n\nVertex announced earlier this week it would acquire Crinetics for "
},
{
"title": "Ascendis Pharma to List Ordinary Shares Directly on Nasdaq",
"url": "https://www.globenewswire.com/news-release/2026/04/08/3270368/0/en/Ascendis-Pharma-to-List-Ordinary-Shares-Directly-on-Nasdaq.html",
"source": "GlobeNewswire Inc.",
"date": "2026-04-08T16:00:00Z",
"summary": "Ascendis Pharma A/S announced plans to list its ordinary shares directly on Nasdaq effective April 20, 2026, with all outstanding American Depositary Shares (ADSs) to be exchanged on a 1:1 basis for ordinary shares. The company believes the direct listing will broaden global inve"
},
{
"title": "FDA Approves Once-Weekly YUVIWEL\u00ae (navepegritide) for Children with Achondroplasia Aged 2 Years and Older",
"url": "https://www.globenewswire.com/news-release/2026/02/27/3246848/0/en/FDA-Approves-Once-Weekly-YUVIWEL-navepegritide-for-Children-with-Achondroplasia-Aged-2-Years-and-Older.html",
"source": "GlobeNewswire Inc.",
"date": "2026-02-27T22:57:00Z",
"summary": "The FDA has granted accelerated approval to YUVIWEL (navepegritide), developed by Ascendis Pharma, as the first and only once-weekly treatment for children aged 2 and older with achondroplasia. The drug provides continuous systemic exposure to CNP over the weekly dosing interval "
},
{
"title": "BridgeBio Nears 52-Week High On Strong Dwarfism Trial Data, Plans FDA Filing In 2026",
"url": "https://www.benzinga.com/markets/large-cap/26/02/50587029/bridgebio-nears-52-week-high-on-strong-dwarfism-trial-data-plans-fda-filing-in-2026?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel",
"source": "Benzinga",
"date": "2026-02-12T17:44:42Z",
"summary": "BridgeBio Pharma announced positive Phase 3 trial results for infigratinib in treating achondroplasia (dwarfism) in children, showing superior annualized height velocity compared to placebo. The company plans to submit FDA and regulatory applications in the second half of 2026. T"
},
{
"title": "Ascendis Pharma Provides Business and Strategic Roadmap Update at 44th Annual J.P. Morgan Healthcare Conference",
"url": "https://www.globenewswire.com/news-release/2026/01/09/3216381/0/en/Ascendis-Pharma-Provides-Business-and-Strategic-Roadmap-Update-at-44th-Annual-J-P-Morgan-Healthcare-Conference.html",
"source": "GlobeNewswire Inc.",
"date": "2026-01-09T23:01:00Z",
"summary": "Ascendis Pharma announced strong 2025 financial results with YORVIPATH generating \u20ac477 million and SKYTROFA generating \u20ac206 million in revenue. The company expects TransCon CNP approval in the U.S. by February 2026 and outlined expansion plans across multiple product candidates a"
},
{
"title": "Ascendis Announces Extension of FDA Review Period for TransCon CNP (navepegritide) for Children with Achondroplasia",
"url": "https://www.globenewswire.com/news-release/2025/11/25/3194804/0/en/Ascendis-Announces-Extension-of-FDA-Review-Period-for-TransCon-CNP-navepegritide-for-Children-with-Achondroplasia.html",
"source": "GlobeNewswire Inc.",
"date": "2025-11-25T23:15:00Z",
"summary": "Ascendis Pharma received notification from the FDA extending the PDUFA target action date for TransCon CNP by three months to February 28, 2026, after submitting additional information for their New Drug Application for treating children with achondroplasia."
}
]
Data:
[
{
"symbol": "ASND",
"date": "2026-08-06",
"epsActual": null,
"epsEstimated": 1.71,
"revenueActual": null,
"revenueEstimated": 376750200,
"lastUpdated": "2026-08-04"
},
{
"symbol": "ASND",
"date": "2026-05-07",
"epsActual": 0.32,
"epsEstimated": 0.1876,
"revenueActual": 284915400,
"revenueEstimated": 308928300,
"lastUpdated": "2026-08-04"
},
{
"symbol": "ASND",
"date": "2026-02-11",
"epsActual": -0.64,
"epsEstimated": -0.06,
"revenueActual": 344844100,
"revenueEstimated": 292258100,
"lastUpdated": "2026-05-11"
},
{
"symbol": "ASND",
"date": "2025-11-12",
"epsActual": -1.17,
"epsEstimated": -0.41,
"revenueActual": 250218822,
"revenueEstimated": 302600555,
"lastUpdated": "2026-02-12"
},
{
"symbol": "ASND",
"date": "2025-08-07",
"epsActual": -0.93,
"epsEstimated": -1.42,
"revenueActual": 186088504,
"revenueEstimated": 233118228,
"lastUpdated": "2025-11-07"
}
]
Data:
{
"borrow": [],
"short_interest": [
{
"symbol": "ASND",
"file_date": "",
"error": "Symbol not found in FINRA biweekly file",
"days_to_cover": null
}
],
"ftd": {
"symbol": "ASND",
"periods": [
{
"file_period": "202603b",
"settlement_date": "20260330",
"quantity_fails": 72,
"price": 216.95
},
{
"file_period": "202604a",
"settlement_date": "20260414",
"quantity_fails": 2405,
"price": 248.55
},
{
"file_period": "202604b",
"settlement_date": "20260430",
"quantity_fails": 5558,
"price": 220.28
},
{
"file_period": "202606a",
"settlement_date": "20260612",
"quantity_fails": 79,
"price": 215.6
},
{
"file_period": "202606b",
"settlement_date": "20260630",
"quantity_fails": 1058,
"price": 263.7
},
{
"file_period": "202607a",
"settlement_date": "20260714",
"quantity_fails": 10013,
"price": 265.22
}
],
"trend": "rising",
"trend_description": "FTD quantity increasing \u2014 settlement pressure building, potential squeeze precursor"
}
}
Data:
{
"insider": [
{
"symbol": "ASND",
"filingDate": "2026-06-02",
"transactionDate": "2026-06-02",
"reportingCik": "0001965550",
"companyCik": "0001612042",
"transactionType": "P-Purchase",
"securitiesOwned": 4367,
"reportingName": "SMITH SCOTT THOMAS",
"typeOfOwner": "officer: EVP & Chief Financial Officer",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 100,
"price": 219,
"securityName": "Ordinary Shares",
"url": "https://www.sec.gov/Archives/edgar/data/1612042/000161071726000179/0001610717-26-000179-index.htm"
},
{
"symbol": "ASND",
"filingDate": "2026-06-01",
"transactionDate": "2026-05-29",
"reportingCik": "0001221590",
"companyCik": "0001612042",
"transactionType": "P-Purchase",
"securitiesOwned": 900,
"reportingName": "BIENAIME JEAN JACQUES",
"typeOfOwner": "director",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 100,
"price": 223.5,
"securityName": "Ordinary Shares",
"url": "https://www.sec.gov/Archives/edgar/data/1612042/000161071726000177/0001610717-26-000177-index.htm"
},
{
"symbol": "ASND",
"filingDate": "2026-06-01",
"transactionDate": "2026-05-29",
"reportingCik": "0001221590",
"companyCik": "0001612042",
"transactionType": "P-Purchase",
"securitiesOwned": 800,
"reportingName": "BIENAIME JEAN JACQUES",
"typeOfOwner": "director",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 200,
"price": 222.3,
"securityName": "Ordinary Shares",
"url": "https://www.sec.gov/Archives/edgar/data/1612042/000161071726000177/0001610717-26-000177-index.htm"
},
{
"symbol": "ASND",
"filingDate": "2026-06-01",
"transactionDate": "2026-05-29",
"reportingCik": "0001221590",
"companyCik": "0001612042",
"transactionType": "P-Purchase",
"securitiesOwned": 600,
"reportingName": "BIENAIME JEAN JACQUES",
"typeOfOwner": "director",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 200,
"price": 223.76,
"securityName": "Ordinary Shares",
"url": "https://www.sec.gov/Archives/edgar/data/1612042/000161071726000177/0001610717-26-000177-index.htm"
},
{
"symbol": "ASND",
"filingDate": "2026-06-01",
"transactionDate": "2026-05-29",
"reportingCik": "0001965550",
"companyCik": "0001612042",
"transactionType": "P-Purchase",
"securitiesOwned": 4267,
"reportingName": "SMITH SCOTT THOMAS",
"typeOfOwner": "officer: EVP & Chief Financial Officer",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 250,
"price": 223.32,
"securityName": "Ordinary Shares",
"url": "https://www.sec.gov/Archives/edgar/data/1612042/000161071726000176/0001610717-26-000176-index.htm"
},
{
"symbol": "ASND",
"filingDate": "2026-06-01",
"transactionDate": "2026-03-18",
"reportingCik": "0001965550",
"companyCik": "0001612042",
"transactionType": "",
"securitiesOwned": 4017,
"reportingName": "SMITH SCOTT THOMAS",
"typeOfOwner": "officer: EVP & Chief Financial Officer",
"acquisitionOrDisposition": "",
"directOrIndirect": "D",
"formType": "3/A",
"securitiesTransacted": 0,
"price": 0,
"securityName": "Ordinary Shares",
"url": "https://www.sec.gov/Archives/edgar/data/1612042/000161071726000175/0001610717-26-000175-index.htm"
},
{
"symbol": "ASND",
"filingDate": "2026-05-27",
"transactionDate": "2026-05-26",
"reportingCik": "0001221590",
"companyCik": "0001612042",
"transactionType": "P-Purchase",
"securitiesOwned": 400,
"reportingName": "BIENAIME JEAN JACQUES",
"typeOfOwner": "director",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 200,
"price": 239.3675,
"securityName": "Ordinary Shares",
"url": "https://www.sec.gov/Archives/edgar/data/1612042/000161071726000161/0001610717-26-000161-index.htm"
},
{
"symbol": "ASND",
"filingDate": "2026-05-27",
"transactionDate": "2026-05-26",
"reportingCik": "0001221590",
"companyCik": "0001612042",
"transactionType": "P-Purchase",
"securitiesOwned": 200,
"reportingName": "BIENAIME JEAN JACQUES",
"typeOfOwner": "director",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 200,
"price": 236.235,
"securityName": "Ordinary Shares",
"url": "https://www.sec.gov/Archives/edgar/data/1612042/000161071726000161/0001610717-26-000161-index.htm"
}
],
"congress": [
"status",
"endpoint",
"provided",
"message",
{
"symbol": "ASND",
"senateID": "",
"disclosureDate": "2018-11-07",
"transactionDate": "2018-10-05",
"firstName": "Gary",
"lastName": "Palmer",
"office": "Gary Palmer",
"district": "aL06",
"owner": "Self",
"assetDescription": "ascendis Pharma a/S - american Depositary Shares (aSND)",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2018/20010611.pdf"
}
],
"dark_pool": [
{
"ticker": "ASND",
"executed_at": "2026-08-04T18:24:57.596000Z",
"size": 400.0,
"price": 244.515,
"premium": 97806.0,
"volume": 400.0,
"trade_code": " "
},
{
"ticker": "ASND",
"executed_at": "2026-08-04T18:24:57.596000Z",
"size": 300.0,
"price": 244.515,
"premium": 73354.5,
"volume": 300.0,
"trade_code": " "
},
{
"ticker": "ASND",
"executed_at": "2026-08-04T18:10:51.280000Z",
"size": 300.0,
"price": 243.55,
"premium": 73065.0,
"volume": 300.0,
"trade_code": " "
},
{
"ticker": "ASND",
"executed_at": "2026-08-04T18:25:10.487000Z",
"size": 200.0,
"price": 244.595,
"premium": 48919.0,
"volume": 200.0,
"trade_code": " "
},
{
"ticker": "ASND",
"executed_at": "2026-08-04T18:21:57.495000Z",
"size": 200.0,
"price": 244.155,
"premium": 48831.0,
"volume": 200.0,
"trade_code": " "
},
{
"ticker": "ASND",
"executed_at": "2026-08-04T18:10:31.214000Z",
"size": 200.0,
"price": 243.555,
"premium": 48711.0,
"volume": 200.0,
"trade_code": " "
},
{
"ticker": "ASND",
"executed_at": "2026-08-04T18:25:50.890000Z",
"size": 100.0,
"price": 244.84,
"premium": 24484.0,
"volume": 100.0,
"trade_code": "F"
},
{
"ticker": "ASND",
"executed_at": "2026-08-04T18:25:50.890000Z",
"size": 100.0,
"price": 244.84,
"premium": 24484.0,
"volume": 100.0,
"trade_code": " "
}
],
"ats": {
"symbol": "ASND",
"date": "20260803",
"ats_volume": 0,
"total_volume": 236724,
"ats_ratio": 0.0,
"ats_pct": 0.0,
"signal": "Low",
"history": [
{
"date": "20260803",
"ats_ratio": 0.0
},
{
"date": "20260731",
"ats_ratio": 0.0
},
{
"date": "20260730",
"ats_ratio": 0.0
},
{
"date": "20260729",
"ats_ratio": 0.0
},
{
"date": "20260728",
"ats_ratio": 0.0
}
]
},
"polygon_dp": {
"ticker": "ASND",
"days": [
{
"date": "2026-08-04",
"close": 244.515,
"vwap": 242.85,
"volume": 365884,
"vwap_discount_pct": -0.68
},
{
"date": "2026-08-03",
"close": 243.45,
"vwap": 243.78,
"volume": 622950,
"vwap_discount_pct": 0.14
},
{
"date": "2026-07-31",
"close": 243.91,
"vwap": 244.79,
"volume": 508877,
"vwap_discount_pct": 0.36
},
{
"date": "2026-07-30",
"close": 251.07,
"vwap": 248.78,
"volume": 475233,
"vwap_discount_pct": -0.91
},
{
"date": "2026-07-29",
"close": 252.05,
"vwap": 254.09,
"volume": 507090,
"vwap_discount_pct": 0.81
}
],
"avg_vwap_discount_pct": -0.06,
"signal": "Neutral"
},
"options_flow": [
{
"implied_volatility": "0.484408847125248",
"volume": 4,
"executed_at": "2026-08-04T15:04:30.135009Z",
"size": 4,
"underlying_price": "241.88",
"underlying_symbol": "ASND",
"premium": "10688.00",
"nbbo_ask": "28.40",
"expiry": "2026-09-18",
"delta": "-0.622338043325334",
"price": "26.72",
"option_type": "put",
"sector": "Healthcare",
"open_interest": 0,
"option_chain_id": "ASND260918P00260000",
"nbbo_bid": "24.70",
"strike": "260"
}
],
"net_premium": {
"ticker": "ASND",
"net_call_premium": "-6877.00",
"net_put_premium": "-1108.00",
"call_premium": "31327.00",
"put_premium": "28424.00",
"bullish_premium": "26691.00",
"bearish_premium": "32460.00",
"put_call_ratio": "0.60000000000000000000",
"iv_rank": "61.2056",
"implied_move_perc": "0.099000",
"gex_ratio": "0.65845075732464111147",
"gex_net_change": "225.5639",
"gex_call_delta": "166768.4514",
"gex_put_delta": "-115275.3158",
"gex_date": "2026-08-04"
},
"hot_chains": [
{
"underlying_symbol": "ASND",
"expires": "2026-09-18",
"open_interest": 0,
"option_type": "call",
"delta": 0.482619659238313,
"ask_volume": 0,
"last_price": "13.60",
"implied_volatility": "0.485031999588185",
"gamma": 0.00985067236009422,
"avg_price": "13.600000000000000000000000000",
"bid_volume": 8,
"nbbo_ask": "15.70",
"strike": "250",
"option_symbol": "ASND260918C00250000",
"total_premium": "10880.00",
"iv": 0.470299288907142,
"volume": 8,
"nbbo_bid": "13.10"
},
{
"underlying_symbol": "ASND",
"expires": "2026-08-21",
"open_interest": 446,
"option_type": "put",
"delta": -0.659338776557341,
"ask_volume": 0,
"last_price": "23.32",
"implied_volatility": "0.582672387682644",
"gamma": 0.01181694813391031,
"avg_price": "23.3120",
"bid_volume": 5,
"nbbo_ask": "25.40",
"strike": "260",
"option_symbol": "ASND260821P00260000",
"total_premium": "11656.00",
"iv": 0.586125854117015,
"volume": 5,
"nbbo_bid": "21.50"
},
{
"underlying_symbol": "ASND",
"expires": "2026-09-18",
"open_interest": 0,
"option_type": "put",
"delta": -0.609950029515227,
"ask_volume": 5,
"last_price": "26.70",
"implied_volatility": "0.483789135860178",
"gamma": 0.00944643634512813,
"avg_price": "26.7160",
"bid_volume": 0,
"nbbo_ask": "28.40",
"strike": "260",
"option_symbol": "ASND260918P00260000",
"total_premium": "13358.00",
"iv": 0.472126913984522,
"volume": 5,
"nbbo_bid": "24.80"
},
{
"underlying_symbol": "ASND",
"expires": "2026-10-16",
"open_interest": 2,
"option_type": "call",
"delta": 0.0862176788310234,
"ask_volume": 2,
"last_price": "2.10",
"implied_volatility": "0.4204659635505134",
"gamma": 0.00349432983056156,
"avg_price": "2.10",
"bid_volume": 0,
"nbbo_ask": "3.80",
"strike": "320",
"option_symbol": "ASND261016C00320000",
"total_premium": "420.00",
"iv": 0.410869480500379,
"volume": 2,
"nbbo_bid": "0.30"
},
{
"underlying_symbol": "ASND",
"expires": "2026-10-16",
"open_interest": 2,
"option_type": "call",
"delta": 0.845662608878346,
"ask_volume": 2,
"last_price": "50.50",
"implied_volatility": "0.481948668288462",
"gamma": 0.0043486103739031,
"avg_price": "50.5000",
"bid_volume": 0,
"nbbo_ask": "51.90",
"strike": "200",
"option_symbol": "ASND261016C00200000",
"total_premium": "10100.00",
"iv": 0.498804028938352,
"volume": 2,
"nbbo_bid": "48.50"
},
{
"underlying_symbol": "ASND",
"expires": "2027-01-15",
"open_interest": 54,
"option_type": "call",
"delta": 0.429014754164506,
"ask_volume": 0,
"last_price": "19.47",
"implied_volatility": "0.4256998683320463",
"gamma": 0.00537691867413676,
"avg_price": "19.0650",
"bid_volume": 2,
"nbbo_ask": "20.10",
"strike": "270",
"option_symbol": "ASND270115C00270000",
"total_premium": "3813.00",
"iv": 0.444762860228085,
"volume": 2,
"nbbo_bid": "19.00"
},
{
"underlying_symbol": "ASND",
"expires": "2027-01-15",
"open_interest": 33,
"option_type": "call",
"delta": 0.1441957251995876,
"ask_volume": 2,
"last_price": "3.97",
"implied_volatility": "0.3601846607460787",
"gamma": 0.00368918629109721,
"avg_price": "3.8900",
"bid_volume": 0,
"nbbo_ask": "5.30",
"strike": "330",
"option_symbol": "ASND270115C00330000",
"total_premium": "778.00",
"iv": 0.374912489921737,
"volume": 2,
"nbbo_bid": "2.60"
},
{
"underlying_symbol": "ASND",
"expires": "2026-08-21",
"open_interest": 325,
"option_type": "call",
"delta": 0.1173738252708684,
"ask_volume": 1,
"last_price": "2.87",
"implied_volatility": "0.572324217868743",
"gamma": 0.00744636156528703,
"avg_price": "2.87",
"bid_volume": 0,
"nbbo_ask": "4.40",
"strike": "280",
"option_symbol": "ASND260821C00280000",
"total_premium": "287.00",
"iv": 0.499562951724084,
"volume": 1,
"nbbo_bid": "0.80"
}
],
"oi_changes": {
"net_call_oi_change": 0,
"net_put_oi_change": 0,
"top": [
{
"strike": "320",
"oi_change": 0,
"type": "call"
},
{
"strike": "330",
"oi_change": 0,
"type": "call"
},
{
"strike": "340",
"oi_change": 0,
"type": "call"
},
{
"strike": "350",
"oi_change": 0,
"type": "call"
},
{
"strike": "210",
"oi_change": 0,
"type": "put"
}
]
}
}
Data:
{
"vix": 17.09,
"sp500": 7437.63,
"fed_funds": 3.63,
"yield_curve_10y2y": 0.45,
"hy_spread": 2.84,
"treasury": {
"date": "2026-07-31",
"month1": 3.78,
"month2": 3.85,
"month3": 3.83,
"month6": 3.98,
"year1": 4.08,
"year2": 4.28,
"year3": 4.34,
"year5": 4.45,
"year7": 4.59,
"year10": 4.75,
"year20": 5.28,
"year30": 5.27
},
"events": [
{
"title": "Average Hourly Earnings m/m",
"currency": "USD",
"date": "2026-08-07",
"time_utc": "12:30",
"impact": "High",
"forecast": "0.3%",
"previous": "0.3%",
"actual": null,
"minutes_until": 3970
},
{
"title": "Non-Farm Employment Change",
"currency": "USD",
"date": "2026-08-07",
"time_utc": "12:30",
"impact": "High",
"forecast": "85K",
"previous": "57K",
"actual": null,
"minutes_until": 3970
},
{
"title": "Unemployment Rate",
"currency": "USD",
"date": "2026-08-07",
"time_utc": "12:30",
"impact": "High",
"forecast": "4.2%",
"previous": "4.2%",
"actual": null,
"minutes_until": 3970
}
]
}
Data:
{
"days": 64,
"patterns": [
{
"name": "VWAP Touch",
"count": 64,
"pct": 100
},
{
"name": "9 EMA Touch",
"count": 64,
"pct": 100
},
{
"name": "21 EMA Touch",
"count": 64,
"pct": 100
},
{
"name": "ORB Breakout",
"count": 63,
"pct": 98
},
{
"name": "Woodie Pivot Touch",
"count": 62,
"pct": 97
},
{
"name": "PDH/PDL Touch",
"count": 56,
"pct": 88
},
{
"name": "Open Retracement",
"count": 54,
"pct": 84
},
{
"name": "Gap Fill",
"count": 50,
"pct": 78
},
{
"name": "Darvas Box",
"count": 24,
"pct": 38
},
{
"name": "High Vol Open",
"count": 17,
"pct": 27
},
{
"name": "Power Hour",
"count": 10,
"pct": 16
}
]
}